Your browser doesn't support javascript.
loading
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Giudice, Ilaria Del; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Poeta, Giovanni Del; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foà, Robin; Gaidano, Gianluca.
Afiliação
  • Diop F; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Moia R; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Favini C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Spaccarotella E; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • De Paoli L; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Bruscaggin A; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Spina V; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Terzi-di-Bergamo L; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Arruga F; Department of Medical Sciences, University of Turin & Italian Institute for Genomic Medicine, Turin, Italy.
  • Tarantelli C; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Deambrogi C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Rasi S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Adhinaveni R; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Patriarca A; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Favini S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Sagiraju S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Jabangwe C; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Kodipad AA; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Peroni D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Mauro FR; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Giudice ID; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Forconi F; Cancer Sciences Unit, Southampton Cancer Research UK and National Institute for Health Research Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Cortelezzi A; Division of Hematology, University of Siena, Siena, Italy.
  • Zaja F; Department of Hematology Oncology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy.
  • Bomben R; Clinica Ematologica, DAME, University of Udine, Udine, Italy.
  • Rossi FM; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Visco C; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Chiarenza A; Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy.
  • Rigolin GM; Division of Hematology, Azienda Ospedaliera Universitaria Policlinico-OVE, Catania, Italy.
  • Marasca R; Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Coscia M; Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy.
  • Perbellini O; Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza and University of Turin, Turin, Italy.
  • Tedeschi A; Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
  • Laurenti L; Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca Granda Hospital, Milan, Italy.
  • Motta M; Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
  • Donaldson D; Department of Hematology, Spedali Civili, Brescia, Italy.
  • Weir P; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
  • Mills K; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
  • Thornton P; Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Lawless S; Department of Haematology, Beaumont Hospital, Dublin, Ireland.
  • Bertoni F; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
  • Poeta GD; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Cuneo A; Department of Hematology, Tor Vergata University, Rome, Italy.
  • Follenzi A; Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Gattei V; Department of Health Sciences, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy.
  • Boldorini RL; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Catherwood M; Department of Pathology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy.
  • Deaglio S; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
  • Foà R; Department of Medical Sciences, University of Turin & Italian Institute for Genomic Medicine, Turin, Italy.
  • Gaidano G; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
Haematologica ; 105(2): 448-456, 2020.
Article em En | MEDLINE | ID: mdl-31371416

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália